Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Vital Edge vs VyrarX

Vital Edge
Graded #235

Lower grade

vs+3.299999999999997
VyrarX
Graded #156

Higher grade

The verdict

VyrarX takes it — 68.3/100 to 65/100.

VyrarX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVyrarX +23
37
60
Dose & formulationVital Edge +24
88
64
Clinical oversightVital Edge +2
86
84
Labs & monitoringVyrarX +19
53
72
FulfillmentVital Edge +1
72
71
Contract termsEven
55
55
Vital Edge · left barVyrarX · right bar

The numbers

MetricVital EdgeVyrarX
WeighScore65/10068.3/100
GradeCC
Scorecard rank#235#156
Semaglutide$350/mo (compounded)$179/mo (starting dose, compounded)
Tirzepatide$450/mo (compounded)$329/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Vital Edge

Graded #235 · C

Strengths

  • Transparent flat monthly pricing published on-site — consult, medication, and shipping all included
  • Broad menu: compounded semaglutide/tirzepatide, compounded oral capsules from $199/mo, plus brand-name Ozempic, Wegovy, Mounjaro and Rybelsus
  • LegitScript-certified (seal #43281221)
  • Flat fee with no upcharge as your dose increases
  • Compounded oral GLP-1 capsules available for needle-free dosing

Where it loses points

  • Compounded injectable pricing ($350 semaglutide / $450 tirzepatide) runs above the lowest-cost telehealth options
  • No compounding pharmacy partner named on the site
  • No named medical director or prescribing clinicians
  • State availability not published — only a nationwide virtual-care claim
  • Small, locally-rooted operation with a limited public track record
VyrarX

Graded #156 · C

Strengths

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

Where it loses points

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard